Business
Thermo Fisher Scientific and SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutions
RIDGEFIELD, N.J., March 25, 2026--Thermo Fisher Scientific Inc., the world leader in serving science, today announced a strategic collaboration with SHL Medical, a leading provider of advanced drug delivery systems, alongside an expansion of sterile fill-finish and autoinjector final assembly capacity at its Ridgefield, NJ site. Together, these investments establish a fully integrated U.S.-based offering spanning sterile manufacturing, device assembly and commercial packaging for drug-device com
About this update from Thermo Fisher Scientific Inc
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1590,"height":341,"url":"https://media.zenfs.com/en/business-wire.com/48ec476ea3010c206940a778dffb1238"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/P7YXP9a0kSYJ6QYlbSd.wA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTIwNg--/https://media.zenfs.com/en/business-wire.com/48ec476ea3010c206940a778dffb1238","width":960,"height":206},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/tGg2NKEStDjRmpQ_vCQMaA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD01MTQ-/https://media.zenfs.com/en/business-wire.com/48ec476ea3010c206940a778dffb1238","width":1200,"height":257}},"lazy":false},{"type":"text","content":"Collaboration and Ridgefield expansion unite fill-finish, device final assembly and packaging in a single U.S. location","length":119,"tagName":"p"},{"type":"text","content":"RIDGEFIELD, N.J., March 25, 2026--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced a strategic collaboration with SHL Medical, a leading provider of advanced drug delivery systems, alongside an expansion of sterile fill-finish and autoinjector final assembly capacity at its Ridgefield, NJ site. Together, these investments establish a fully integrated U.S.-based offering spanning sterile manufacturing, device assembly and commercial packaging for drug-device combination products.","length":535,"tagName":"p"},{"type":"text","content":"Demand for patient-centric, self-administered injectable therapies continues to grow across multiple therapeutic areas including autoimmune diseases, inflammatory conditions, and other chronic diseases. To meet this need, Thermo Fisher is expanding pre-filled syringe (PFS) fill-finish and device assembly in Ridgefield. In parallel, its strategic partnership with SHL Medical enables integration of SHL Medical's Molly® autoinjector platform with Thermo Fisher’s sterile manufacturing network, creating a seamless, end-to-end solution from drug product to finished device.","length":577,"tagName":"p"},{"type":"text","content":"Thermo Fisher acquired the Ridgefield facility from Sanofi in September 2025 as part of its strategy to strengthen its U.S. manufacturing footprint. The site is being developed as a premier North American hub for integrated sterile fill-finish, au...